Heart attack breakthrough? common diabetes drugs tested to save lives
NCT ID NCT06903754
Summary
This study tested whether adding a once-daily diabetes medication (dapagliflozin or empagliflozin) to standard treatment could help non-diabetic patients who recently had a serious heart attack. The goal was to see if these drugs could reduce future hospitalizations for heart failure, prevent repeat heart attacks, and lower the risk of death. The trial involved 450 patients who had a heart attack and some degree of heart weakness but did not have diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mohammed VI university hospital oujda
OUDA, Morocco
Conditions
Explore the condition pages connected to this study.